XML 18 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Ordinary shares
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive loss
Retained earnings (accumulated deficit)
Retained earnings (accumulated deficit)
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2019     99,528,435          
Beginning balance at Dec. 31, 2019 $ 217,790     $ 871,442   $ (2,767) $ (650,885)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation to employees 16,557     16,557        
Exercise of options and vested RSUs (in shares)     834,538          
Exercise of options and vested RSUs 4,511     4,511        
Other comprehensive income (loss), net of tax benefit (862)         (862)    
Net income (loss) 3,952           3,952  
Ending balance (in shares) at Mar. 31, 2020     100,362,973          
Ending balance at Mar. 31, 2020 241,948     892,510   (3,629) (646,933)  
Beginning balance (in shares) at Dec. 31, 2019     99,528,435          
Beginning balance at Dec. 31, 2019 217,790     871,442   (2,767) (650,885)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 5,607              
Ending balance (in shares) at Jun. 30, 2020     101,020,721          
Ending balance at Jun. 30, 2020 267,822     916,632   (3,532) (645,278)  
Beginning balance (in shares) at Dec. 31, 2019     99,528,435          
Beginning balance at Dec. 31, 2019 $ 217,790     871,442   (2,767) (650,885)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Accounting standards update [extensible enumeration] us-gaap:AccountingStandardsUpdate202006Member              
Net income (loss) $ 19,808              
Ending balance (in shares) at Dec. 31, 2020     102,334,276          
Ending balance at Dec. 31, 2020 476,526 $ (128,972)   1,111,435 $ (132,474) (3,832) (631,077) $ 3,502
Beginning balance (in shares) at Mar. 31, 2020     100,362,973          
Beginning balance at Mar. 31, 2020 241,948     892,510   (3,629) (646,933)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation to employees 18,770     18,770        
Proceeds from issuance of shares (in shares)     33,075          
Proceeds from issuance of shares 1,667     1,667        
Exercise of options and warrants and vested RSUs (in shares)     624,673          
Exercise of options and vested RSUs 3,685     3,685        
Other comprehensive income (loss), net of tax benefit 97         97    
Net income (loss) 1,655           1,655  
Ending balance (in shares) at Jun. 30, 2020     101,020,721          
Ending balance at Jun. 30, 2020 267,822     916,632   (3,532) (645,278)  
Beginning balance (in shares) at Dec. 31, 2020     102,334,276          
Beginning balance at Dec. 31, 2020 476,526 (128,972)   1,111,435 (132,474) (3,832) (631,077) 3,502
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation to employees 18,863     18,863        
Exercise of options and vested RSUs (in shares)     853,184          
Exercise of options and vested RSUs 7,961     7,961        
Other comprehensive income (loss), net of tax benefit 1,884         1,884    
Net income (loss) (4,128)           (4,128)  
Ending balance (in shares) at Mar. 31, 2021     103,187,460          
Ending balance at Mar. 31, 2021 372,134     1,005,785   (1,948) (631,703)  
Beginning balance (in shares) at Dec. 31, 2020     102,334,276          
Beginning balance at Dec. 31, 2020 476,526 $ (128,972)   1,111,435 $ (132,474) (3,832) (631,077) $ 3,502
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (18,769)              
Ending balance (in shares) at Jun. 30, 2021     103,641,238          
Ending balance at Jun. 30, 2021 397,269     1,044,732   (1,119) (646,344)  
Beginning balance (in shares) at Mar. 31, 2021     103,187,460          
Beginning balance at Mar. 31, 2021 372,134     1,005,785   (1,948) (631,703)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation to employees 27,881     27,881        
Proceeds from issuance of shares (in shares)     17,291          
Proceeds from issuance of shares 2,371     2,371        
Exercise of options and vested RSUs (in shares)     436,487          
Exercise of options and vested RSUs 8,695     8,695        
Other comprehensive income (loss), net of tax benefit 829         829    
Net income (loss) (14,641)           (14,641)  
Ending balance (in shares) at Jun. 30, 2021     103,641,238          
Ending balance at Jun. 30, 2021 $ 397,269     $ 1,044,732   $ (1,119) $ (646,344)